Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03225755 · ClinicalTrials.gov registry record
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 7
- Enrollment target
NCT03225755 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 7 participants.
The verdict
NCT03225755 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
In order to examine the effect of GH on adipose tissue inflammation, this study will examine adipose tissue and serum inflammation in patients with GH deficiency before and after GH therapy. The investigators will also obtain serum samples before and after treatment for adipokines, inflammatory markers and examine macrophages in circulation with regard to their inflammatory state. The investigators will also obtain adipose tissue biopsies from healthy subjects matched to the growth hormone deficiency (GHD) subjects. Adipose tissue specimens will be analyzed for adipose tissue morphology, adipocyte size, adipokine gene expression, and adipose tissue macrophage number.
Interventions
- DRUG Growth hormone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2025-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03225755
The ClinicalTrials.gov registry entry for NCT03225755 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Growth hormone is the first listed.
NCT03225755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03225755 about?
NCT03225755 is a clinical study titled "Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy". In order to examine the effect of GH on adipose tissue inflammation, this study will examine adipose tissue and serum inflammation in patients with GH deficiency before and after GH therapy. The investigators will also obtain serum samples before and after treatment for adipokines, inflammatory mark...
What is the current status of trial NCT03225755?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2017-08-01. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT03225755?
The interventions under investigation include: Growth hormone (DRUG).
Who is sponsoring clinical trial NCT03225755?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.